Veronique M. Braud
Valbonne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Human keratinocytes exhibit limited potential for SARS-CoV-2 infection despite ACE2 and mature cathepsin L expression.
Journal: JID innovations : skin science from molecules to population health
Published: September 14, 2025
Tumor growth and immune response: On the impact of the space-structuration of the tumor microenvironment.
Journal: Mathematical biosciences
Published: May 23, 2025
CD206+CD14- Skin-Resident Macrophages and DC-T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma.
Journal: Cancer immunology research
Published: February 12, 2025
Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin.
Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin.
Journal: Frontiers in medicine
Published: September 05, 2024
A mixture-like model for tumor-immune system interactions.
Journal: Journal of theoretical biology
Published: March 27, 2023
Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
Journal: International journal of molecular sciences
Published: March 08, 2023
Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma.
Journal: Frontiers in immunology
Published: March 23, 2022
Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment.
Journal: Frontiers in oncology
Published: February 18, 2022
Highlights of the UCAncer 2021 symposium on multidisciplinary approaches to cancer research
Journal: Bulletin du cancer
Published: January 10, 2022
LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Journal: Frontiers in immunology
Published: January 02, 2022
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Journal: Journal for immunotherapy of cancer
Published: November 21, 2021
Last Updated: 09/26/2026